Skip to main content
. 2023 Sep 2;15(17):4395. doi: 10.3390/cancers15174395

Table 2.

This table summarizes all relevant oncological data of the patients included in this study. The numbers are separately listed for each MDT/SB as well as overall.

OVERALL MDT-SB/A MDT-SB/B p-Value
Total number of patients 983 610 373 <0.001
Total number of presentations 1556 914 642 <0.001
OVERALL MDT-SB/A MDT-SB/B p-value
1st time presentations 650 416 234 <0.001
Follow-up presentations 833 431 402 <0.001
Dignity: 1st time/fup presentation
    Benign
Intermediate
    Malignant
    Simulator
    Metastasis
    Blood
    Others
650/833
120/70
135/50
186/548
43/20
10/4
53/11
103/30
416/431
105/54
61/77
99/256
35/13
10/4
9/1
97/26
234/402
15/16
74/3
97/292
8/7
0/0
44/10
6/4
<0.001/0.17
<0.001/<0.001
<0.001/<0.93
<0.001/<0.001
0.01/0.26
0.02/0.13
<0.01/0.005
<0.01/<0.01
Localization: 1st time/fup presentation
    Bone
    Deep soft tissues
    Superficial soft tissues
NA
650/833
117/141
431/579
95/103
7/10
416/431
77/76
269/290
70/62
0/3
234/402
40/65
162/289
28/41
4/7
<0.001/0.17
0.67/0.58
0.26/0.15
0.11/0.07
0.02/0.21
1st time & intermediate/malignant
    Bone
    Deep soft tissues
    Superficial soft tissues
321
48
224
49
160
20
111
29
161
28
113
20
0.99
0.27
0.90
0.17
Total number of biopsies
    Bone
    Deep soft tissues
    Superficial soft tissues
782
133
518
131
523
82
348
93
259
51
170
38
<0.001
0.19
0.81
0.31
Indications for surgery
    Bone
    Deep soft tissues
    Superficial soft tissues
393
70
259
64
244
38
161
45
149
32
98
19
0.77
0.17
0.99
0.16
Indications for radiotherapy
    Bone
    Deep soft tissues
    Superficial soft tissues
98
5
73
20
46
2
33
11
52
3
40
9
0.48
0.99
0.65
0.46
Indications for chemotherapy
    Bone
    Deep soft tissues
    Superficial soft tissues
106
28
70
8
23
9
14
0
83
19
56
8
<0.001
0.18
0.62
0.20